| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Innovation Pharmaceuticals Inc. | CEO and Chairman, Director | Class B Common Stock | 4,333,936 | 30 Dec 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000147793223000086-ehrlich-leo-2022-12-30 | Innovation Pharmaceuticals Inc. | 30 Dec 2022 | 1 | $0 | 4 | CEO and Chairman, Director | 04 Jan 2023, 15:15 |
| /report/000147793222007272-ehrlich-leo-2020-02-23 | Innovation Pharmaceuticals Inc. | 23 Feb 2020 | 13 | -$328,176 | 4 | CEO and Chairman, Director | 28 Sep 2022, 12:03 |